BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1903340)

  • 1. Antimicrobial activity of subinhibitory concentrations of aminoglycosides against Pseudomonas aeruginosa as determined by the killing-curve method and the postantibiotic effect.
    Zhanel GG; Karlowsky JA; Hoban DJ; Davidson RJ
    Chemotherapy; 1991; 37(2):114-21. PubMed ID: 1903340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activity of subinhibitory concentrations of ciprofloxacin against Pseudomonas aeruginosa as determined by the killing curve method and the postantibiotic effect.
    Zhanel GG; Crampton J; Kim S; Nicolle LE; Davidson RJ; Hoban DJ
    Chemotherapy; 1992; 38(6):388-94. PubMed ID: 1288962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-lactamase induction and aminoglycoside susceptibility in Pseudomonas aeruginosa.
    Stratton CW; Weeks LS; Tausk F
    J Antimicrob Chemother; 1987 Jan; 19(1):21-5. PubMed ID: 3104276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
    Washington JA; Snyder RJ; Kohner PC; Wiltse CG; Ilstrup DM; McCall JT
    J Infect Dis; 1978 Feb; 137(2):103-11. PubMed ID: 415096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibility of Pseudomonas aeruginosa to aminoglycosides: effect of free calcium and magnesium].
    Christe M; Vaudaux P; Waldvogel FA
    Schweiz Med Wochenschr; 1982 Feb; 112(7):234-41. PubMed ID: 6803358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
    Drugeon HB; Courtieu AL
    Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of aminoglycosides and cephalosporins against Pseudomonas aeruginosa. Correlation between interaction index and killing curve.
    Perea EJ; Clavijo E; Nogales MC; García Luque IG
    J Antimicrob Chemother; 1988 Aug; 22(2):175-83. PubMed ID: 3141342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro bactericidal activity of tobramycin and amikacin alone or in combination against Pseudomonas aeruginosa isolated from patients with cystic fibrosis].
    Bertrou A; Marty N; Henry S; Agueda L; Chabanon G
    Pathol Biol (Paris); 1990 May; 38(5):366-75. PubMed ID: 2114606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
    Pfaller M; Bale M; Preston T; Howard W; Koontz F
    Diagn Microbiol Infect Dis; 1986 May; 5(1):17-23. PubMed ID: 3086026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp.
    Baltch AL; Smith RP; Ritz W
    Chemotherapy; 1994; 40(6):391-8. PubMed ID: 7842822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
    Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postantibiotic effect of aminoglycosides on gram-negative bacteria evaluated by a new method.
    Isaksson B; Nilsson L; Maller R; Sörén L
    J Antimicrob Chemother; 1988 Jul; 22(1):23-33. PubMed ID: 3139614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The combined effects of aspoxicillin with aminoglycoside antibiotics on Pseudomonas aeruginosa].
    Matsushita T; Kasuga O; Yamaguchi T
    Jpn J Antibiot; 1990 Apr; 43(4):677-85. PubMed ID: 2116537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of gentamicin-resistant Pseudomonas aeruginosa.
    Yu PK; Washington JA
    Mayo Clin Proc; 1977 Dec; 52(12):802-5. PubMed ID: 413013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of Synergistic Combination Regimens against Carbapenem- and Aminoglycoside-Resistant Clinical Pseudomonas aeruginosa Isolates via Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling.
    Yadav R; Bulitta JB; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical comparative evaluation of aminoglycosides.
    Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
    Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of the sensitivity of Enterobacteriaceae and Pseudomonas aeruginosa with 4 aminoglycosides].
    Turgeon P; Lamothe F; Vincelette J; Gaudreau C; Bourgault AM; Turgeon F
    Union Med Can; 1984 Jun; 113(6):522-4. PubMed ID: 6435299
    [No Abstract]   [Full Text] [Related]  

  • 20. Microdilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli with a cation-supplemented inoculum.
    Cherne JE; Peterson LR
    Antimicrob Agents Chemother; 1980 Jul; 18(1):210-1. PubMed ID: 6774664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.